|
STOCKHOLDERS' EQUITY (Details) (Warrant [Member], USD $)
|
3 Months Ended |
|---|---|
|
Mar. 31, 2015
|
|
|
Warrant [Member]
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
| Number of Warrants, Outstanding, December 31, 2014 (in shares) |
1,069,674us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Number of Warrants, Issued |
53,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Number of Warrants, Exercised |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Number of Warrants, Expired |
0cik0001559998_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Number of Warrants, Outstanding, March 31, 2015 (in shares) |
1,122,674us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Number of Warrants, Exercisable, March 31, 2015 (in shares) |
1,122,674cik0001559998_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionExercisableNumber / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Exercise Price, Outstanding, December 31, 2014 (in dollars per share) |
$ 2.26cik0001559998_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Exercise Price, Issued |
$ 2cik0001559998_SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Exercise Price, Exercised |
$ 0cik0001559998_SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Exercise Price, Expired |
$ 0cik0001559998_SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriodWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Exercise Price, Outstanding, March 31, 2015 (in dollars per share) |
$ 2.26cik0001559998_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Exercise Price, Exercisable, March 31, 2015 (in dollars per share) |
$ 2.26cik0001559998_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageExercisePrice / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Weighted Average Remaining Life In Years, Outstanding, March 31, 2015 | 3 years 3 months 18 days |
| Weighted Average Remaining Life In Years, Exercisable, March 31, 2015 | 3 years 3 months 18 days |
| Intrinsic Value, Outstanding, March 31, 2015 (in dollars) |
$ 18,913us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| Intrinsic Value, Exercisable, March 31, 2015 (in dollars) |
$ 18,913cik0001559998_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable / us-gaap_StatementEquityComponentsAxis = us-gaap_WarrantMember |
| X | ||||||||||
|
- Definition
The number of shares into which fully or partially vested other than options outstanding as of the balance sheet date can be currently converted under the option plan. No definition available.
|
| X | ||||||||||
|
- Definition
Intrinsic value of equity-based compensation awards exercisable. Excludes stock and unit options. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average exercisable price of nonvested awards on equity-based plans excluding option plans. No definition available.
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, and are exercisable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were expired during the reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average price of nonvested awards on equity-based plans excluding option plans. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average price of nonvested equity-based awards exercised during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average price of nonvested equity-based awards expired during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
|
- Definition
The weighted average price of nonvested equity-based awards issued during the period on other than stock (or unit) option plans. No definition available.
|
| X | ||||||||||
|
- Definition
Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options. No definition available.
|
| X | ||||||||||
|
- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|